Identifier
Created
Classification
Origin
09STATE99707
2009-09-24 19:43:00
UNCLASSIFIED
Secretary of State
Cable title:
FOLLOW-UP ON PRESIDENT'S ANNOUNCEMENT TO EXPAND
how-toVZCZCXRO3810 PP RUEHSL DE RUEHC #9707/01 2672002 ZNR UUUUU ZZH P 241943Z SEP 09 FM SECSTATE WASHDC TO RUEHAD/AMEMBASSY ABU DHABI PRIORITY 5110 RUEHAK/AMEMBASSY ANKARA PRIORITY 0191 RUEHTH/AMEMBASSY ATHENS PRIORITY 1272 RUEHBJ/AMEMBASSY BEIJING PRIORITY 0520 RUEHRL/AMEMBASSY BERLIN PRIORITY 3702 RUEHSL/AMEMBASSY BRATISLAVA PRIORITY 0468 RUEHBS/AMEMBASSY BRUSSELS PRIORITY 5036 RUEHUP/AMEMBASSY BUDAPEST PRIORITY 7736 RUEHCP/AMEMBASSY COPENHAGEN PRIORITY 0993 RUEHDO/AMEMBASSY DOHA PRIORITY 1359 RUEHDL/AMEMBASSY DUBLIN PRIORITY 1078 RUEHHE/AMEMBASSY HELSINKI PRIORITY 2355 RUEHLI/AMEMBASSY LISBON PRIORITY 7902 RUEHLE/AMEMBASSY LUXEMBOURG PRIORITY 6039 RUEHMD/AMEMBASSY MADRID PRIORITY 2674 RUEHMO/AMEMBASSY MOSCOW PRIORITY 4058 RUEHNE/AMEMBASSY NEW DELHI PRIORITY 6910 RUEHOT/AMEMBASSY OTTAWA PRIORITY 6694 RUEHPG/AMEMBASSY PRAGUE PRIORITY 0994 RUEHRK/AMEMBASSY REYKJAVIK PRIORITY 9755 RUEHRH/AMEMBASSY RIYADH PRIORITY 3459 RUEHUL/AMEMBASSY SEOUL PRIORITY 1979 RUEHSM/AMEMBASSY STOCKHOLM PRIORITY 8109 RUEHTC/AMEMBASSY THE HAGUE PRIORITY 6419 RUEHKO/AMEMBASSY TOKYO PRIORITY 0612 RUEHVI/AMEMBASSY VIENNA PRIORITY 9520 RUEHWR/AMEMBASSY WARSAW PRIORITY 4892 INFO RUEHSW/AMEMBASSY BERN PRIORITY 6587 RUEHBR/AMEMBASSY BRASILIA PRIORITY 4270 RUEHBY/AMEMBASSY CANBERRA PRIORITY 5312 RUEHLO/AMEMBASSY LONDON PRIORITY 6856 RUEHNY/AMEMBASSY OSLO PRIORITY 8723 RUEHFR/AMEMBASSY PARIS PRIORITY 6426 RUEHRO/AMEMBASSY ROME PRIORITY 2436 RUEHWL/AMEMBASSY WELLINGTON PRIORITY 0360 RUCNDT/USMISSION USUN NEW YORK PRIORITY 7856 RUEHGV/USMISSION GENEVA PRIORITY 9293
UNCLAS SECTION 01 OF 04 STATE 099707
SIPDIS
BRUSSELS ALSO FOR EU
E.O. 12958: N/A
TAGS: AORC PREL KFLU WHO
SUBJECT: FOLLOW-UP ON PRESIDENT'S ANNOUNCEMENT TO EXPAND
FIGHT AGAINST GLOBAL H1N1 PANDEMIC
REF: STATE 97471 (NOTAL)
UNCLAS SECTION 01 OF 04 STATE 099707
SIPDIS
BRUSSELS ALSO FOR EU
E.O. 12958: N/A
TAGS: AORC PREL KFLU WHO
SUBJECT: FOLLOW-UP ON PRESIDENT'S ANNOUNCEMENT TO EXPAND
FIGHT AGAINST GLOBAL H1N1 PANDEMIC
REF: STATE 97471 (NOTAL)
1. This is an action request. See paragraph six.
2. Background. On September 17, 2009, President Obama
announced that the United States will act aggressively to
stop the global spread of the pandemic 2009-H1N1 virus
through partnering with the World Health Organization (WHO)
to make 10 percent of the U.S. H1N1 vaccine supply available
to other countries. Other governments are joining with the
United States in this effort -- Australia, Brazil, France,
Italy, New Zealand, Norway, Switzerland, and the United
Kingdom. Similar announcements have been made to date by
all except Brazil. The purpose of this cable is to solicit
assistance from countries not included in the first round of
the initiative.
3. Following is the text of the President's announcement of
September 17 which can be found at www.whitehouse.gov.
Begin text.
The White House
Office of the Press Secretary
President Announces Plan to Expand Fight Against Global H1N1
Pandemic
Today, President Obama announced the United States will
continue to act aggressively to stop the global spread of the
pandemic 2009-H1N1 influenza virus and is prepared to make 10
percent of its H1N1 vaccine available to other countries
through the WHO. In recognition that diseases know no
borders and that the health of the American people is
inseparable from the health of people around the world, the
United States is taking this action in concert with
Australia, Brazil, France, Italy, New Zealand, Norway,
Switzerland, and the United Kingdom. The United States will
make the H1N1 vaccine available to the WHO on a rolling basis
as vaccine supplies become available, in order to assist
countries that will not otherwise have direct access to the
vaccine.
This week, the Food and Drug Administration officially
licensed the 2009-H1N1 influenza vaccine. Last week, the
Department of Health and Human Services and the National
Institutes of Health announced that one dose of the vaccine -
instead of two doses - will be effective in developing
immunity in most adults, and HHS Secretary Sebelius announced
the vaccine would be available in the coming weeks, earlier
than originally anticipated. We remain confident that the
STATE 00099707 002 OF 004
United States will have sufficient doses of the vaccine to
ensure that every American who wants a vaccine is able to
receive one. We continue to recommend that early priority at
home and abroad should be given to pregnant women, health
care workers, individuals caring for infants less than 6
months of age, and other high-risk populations.
There is broad international recognition that the 2009-H1N1
pandemic presents a global health risk. Millions of people
around the world have been affected, thousands have died and
the virus continues to spread across international borders.
The United States recognizes that just as this challenge
transcends borders, so must our response. We invite other
nations to join in this urgent global health effort. Working
together, we can ensure that this vaccine limits the spread
of the disease, reduces the burden on health care systems,
reduces the risk of an even more virulent strain emerging
and, most importantly, saves lives -- in the United States
and around the world.
End text.
4. The H1N1 initiative grew out of recognition that H1N1
is a global health risk requiring a global response.
We have encouraged donations in a variety of
ways, including: 1) funding for vaccine or non-vaccine
contributions (such as technical capacity to enable timely
delivery in-country, syringes, gowns, medical and protective
equipment); 2) donation of vaccine purchased by the donor
government, and 3) joining with the United States in an
effort to free up contracted manufacturing capacity so that
it can be allocated to the WHO. The question of timing for
vaccine delivery is an important factor in the collective
response, with earlier delivery being more efficacious
against
the pandemic.
5. Reftel was sent September 18 to capitals involved in the
original announcement of the initiative (see para 3) seeking
additional clarity on their commitments to donate portions of
national vaccine supplies, or other significant assistance
such
as money for technical assistance. Germany announced
September 24 that it would provide 20 million euros
(approximately million dollars) to help developing
countries fight H1N1. End Background
6. Action Request. Posts are requested to approach senior
host government officials to ask that they consider
contributing vaccines, funding, technical support or
medical supplies to WHO to help developing countries and to
identify the appropriate points of contact for any follow-up.
For Ottawa: The issue has been raised in Washington with
Canadian DCM Saint-Jacques. Canada expressed interest in
STATE 00099707 003 OF 004
donating vaccine or providing support through other
mechanisms,
but was unable to conclude its review in time to be included
in the original announcement.
For Tokyo: The issue has been raised in Washington with
Japanese Economic Counselor Hayashi. Japan expressed
interest
in donating vaccine or providing support through other
mechanisms, but was unable to conclude its review in time to
be
included in the original announcement.
For Berlin -- Please express appreciation for 20 million Euro
donation Germany announced September 24, 2009 while seeking
further details and contact information per talking points
below.
Responses are requested by September 29. Please slug for
OES/IHB (Jones) and IO/HS (Blackwood).
7. Talking Points.
--The United States and Australia, Brazil, France, Italy,
New Zealand, Norway, Switzerland, and the United Kingdom are
working to provide assistance, including vaccines, to help
developing countries respond to the global challenge posed by
the H1N1 pandemic. Other countries are considering joining
this
effort.
--We ask you to consider on an urgent basis whether your
government/the EU can contribute to this common effort to
combat the global H1N1 pandemic.
-- Donations can be made in a variety of ways, including:
1) funding for vaccine or non-vaccine contributions (such as
technical capacity to enable timely delivery in-country and
medical supplies); 2) direct donation of vaccine purchased by
your
government, or 3) freeing up vaccine manufacturing capacity
for WHO purchase on favorable terms to be negotiated between
WHO and the manufacturers. If countries choose to free up
capacity,
it might be worthwhile to considering doing so in a
coordinated
fashion. We would welcome your government joining with the
United States and our other partners in this global effort.
-- To ensure effective coordination between donors and the WHO
we would appreciate information on any assistance you may be
able to provide and its timing. Since plans may still be
under
development, we would like to be kept informed of about yours,
and intend to share our own.
STATE 00099707 004 OF 004
-- The United States will work to facilitate contacts between
relevant officials in our respective governments, as well as
WHO. Please provide the names and contact information of the
appropriate officials in your government for any follow-up.
--
CLINTON
SIPDIS
BRUSSELS ALSO FOR EU
E.O. 12958: N/A
TAGS: AORC PREL KFLU WHO
SUBJECT: FOLLOW-UP ON PRESIDENT'S ANNOUNCEMENT TO EXPAND
FIGHT AGAINST GLOBAL H1N1 PANDEMIC
REF: STATE 97471 (NOTAL)
1. This is an action request. See paragraph six.
2. Background. On September 17, 2009, President Obama
announced that the United States will act aggressively to
stop the global spread of the pandemic 2009-H1N1 virus
through partnering with the World Health Organization (WHO)
to make 10 percent of the U.S. H1N1 vaccine supply available
to other countries. Other governments are joining with the
United States in this effort -- Australia, Brazil, France,
Italy, New Zealand, Norway, Switzerland, and the United
Kingdom. Similar announcements have been made to date by
all except Brazil. The purpose of this cable is to solicit
assistance from countries not included in the first round of
the initiative.
3. Following is the text of the President's announcement of
September 17 which can be found at www.whitehouse.gov.
Begin text.
The White House
Office of the Press Secretary
President Announces Plan to Expand Fight Against Global H1N1
Pandemic
Today, President Obama announced the United States will
continue to act aggressively to stop the global spread of the
pandemic 2009-H1N1 influenza virus and is prepared to make 10
percent of its H1N1 vaccine available to other countries
through the WHO. In recognition that diseases know no
borders and that the health of the American people is
inseparable from the health of people around the world, the
United States is taking this action in concert with
Australia, Brazil, France, Italy, New Zealand, Norway,
Switzerland, and the United Kingdom. The United States will
make the H1N1 vaccine available to the WHO on a rolling basis
as vaccine supplies become available, in order to assist
countries that will not otherwise have direct access to the
vaccine.
This week, the Food and Drug Administration officially
licensed the 2009-H1N1 influenza vaccine. Last week, the
Department of Health and Human Services and the National
Institutes of Health announced that one dose of the vaccine -
instead of two doses - will be effective in developing
immunity in most adults, and HHS Secretary Sebelius announced
the vaccine would be available in the coming weeks, earlier
than originally anticipated. We remain confident that the
STATE 00099707 002 OF 004
United States will have sufficient doses of the vaccine to
ensure that every American who wants a vaccine is able to
receive one. We continue to recommend that early priority at
home and abroad should be given to pregnant women, health
care workers, individuals caring for infants less than 6
months of age, and other high-risk populations.
There is broad international recognition that the 2009-H1N1
pandemic presents a global health risk. Millions of people
around the world have been affected, thousands have died and
the virus continues to spread across international borders.
The United States recognizes that just as this challenge
transcends borders, so must our response. We invite other
nations to join in this urgent global health effort. Working
together, we can ensure that this vaccine limits the spread
of the disease, reduces the burden on health care systems,
reduces the risk of an even more virulent strain emerging
and, most importantly, saves lives -- in the United States
and around the world.
End text.
4. The H1N1 initiative grew out of recognition that H1N1
is a global health risk requiring a global response.
We have encouraged donations in a variety of
ways, including: 1) funding for vaccine or non-vaccine
contributions (such as technical capacity to enable timely
delivery in-country, syringes, gowns, medical and protective
equipment); 2) donation of vaccine purchased by the donor
government, and 3) joining with the United States in an
effort to free up contracted manufacturing capacity so that
it can be allocated to the WHO. The question of timing for
vaccine delivery is an important factor in the collective
response, with earlier delivery being more efficacious
against
the pandemic.
5. Reftel was sent September 18 to capitals involved in the
original announcement of the initiative (see para 3) seeking
additional clarity on their commitments to donate portions of
national vaccine supplies, or other significant assistance
such
as money for technical assistance. Germany announced
September 24 that it would provide 20 million euros
(approximately million dollars) to help developing
countries fight H1N1. End Background
6. Action Request. Posts are requested to approach senior
host government officials to ask that they consider
contributing vaccines, funding, technical support or
medical supplies to WHO to help developing countries and to
identify the appropriate points of contact for any follow-up.
For Ottawa: The issue has been raised in Washington with
Canadian DCM Saint-Jacques. Canada expressed interest in
STATE 00099707 003 OF 004
donating vaccine or providing support through other
mechanisms,
but was unable to conclude its review in time to be included
in the original announcement.
For Tokyo: The issue has been raised in Washington with
Japanese Economic Counselor Hayashi. Japan expressed
interest
in donating vaccine or providing support through other
mechanisms, but was unable to conclude its review in time to
be
included in the original announcement.
For Berlin -- Please express appreciation for 20 million Euro
donation Germany announced September 24, 2009 while seeking
further details and contact information per talking points
below.
Responses are requested by September 29. Please slug for
OES/IHB (Jones) and IO/HS (Blackwood).
7. Talking Points.
--The United States and Australia, Brazil, France, Italy,
New Zealand, Norway, Switzerland, and the United Kingdom are
working to provide assistance, including vaccines, to help
developing countries respond to the global challenge posed by
the H1N1 pandemic. Other countries are considering joining
this
effort.
--We ask you to consider on an urgent basis whether your
government/the EU can contribute to this common effort to
combat the global H1N1 pandemic.
-- Donations can be made in a variety of ways, including:
1) funding for vaccine or non-vaccine contributions (such as
technical capacity to enable timely delivery in-country and
medical supplies); 2) direct donation of vaccine purchased by
your
government, or 3) freeing up vaccine manufacturing capacity
for WHO purchase on favorable terms to be negotiated between
WHO and the manufacturers. If countries choose to free up
capacity,
it might be worthwhile to considering doing so in a
coordinated
fashion. We would welcome your government joining with the
United States and our other partners in this global effort.
-- To ensure effective coordination between donors and the WHO
we would appreciate information on any assistance you may be
able to provide and its timing. Since plans may still be
under
development, we would like to be kept informed of about yours,
and intend to share our own.
STATE 00099707 004 OF 004
-- The United States will work to facilitate contacts between
relevant officials in our respective governments, as well as
WHO. Please provide the names and contact information of the
appropriate officials in your government for any follow-up.
--
CLINTON